These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1763689)

  • 1. Halothane inhibits binding of calcium channel blockers to cardiac sarcolemma.
    Drenger B; Runge SR; Hoehner P; Quigg M; Blanck TJ
    Adv Exp Med Biol; 1991; 301():109-14. PubMed ID: 1763689
    [No Abstract]   [Full Text] [Related]  

  • 2. Volatile anesthetics depress calcium channel blocker binding to bovine cardiac sarcolemma.
    Drenger B; Quigg M; Blanck TJ
    Anesthesiology; 1991 Jan; 74(1):155-65. PubMed ID: 1986641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halothane depresses D600 binding to bovine heart sarcolemma.
    Hoehner PJ; Quigg MC; Blanck TJ
    Anesthesiology; 1991 Dec; 75(6):1019-24. PubMed ID: 1741494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of nitrendipine and Bay k 8644 binding to isolated canine heart sarcolemma with their pharmacological effects on the canine heart.
    Vaghy PL; Grupp IL; Grupp G; Balwierczak JL; Williams JS; Schwartz A
    Eur J Pharmacol; 1984 Jul; 102(2):373-4. PubMed ID: 6207033
    [No Abstract]   [Full Text] [Related]  

  • 5. Halothane modifies ischemia-associated injury to the voltage-sensitive calcium channels in canine heart sarcolemma.
    Drenger B; Ginosar Y; Chandra M; Reches A; Gozal Y
    Anesthesiology; 1994 Jul; 81(1):221-8. PubMed ID: 8042789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of volatile anesthetics on the intracellular calcium transient and calcium current in cardiac muscle cells.
    Bosnjak ZJ
    Adv Exp Med Biol; 1991; 301():97-107. PubMed ID: 1662468
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible interaction between halothane and Ca++ on cardiac actomyosin adenosine triphosphatase: mechanism and significance.
    Merin RG; Kumazawa T; Honig CR
    J Pharmacol Exp Ther; 1974 Jul; 190(1):1-14. PubMed ID: 4277010
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of gallopamil on excitation-contraction coupling.
    Zucchi R
    Gen Pharmacol; 1996 Jul; 27(5):749-53. PubMed ID: 8842675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.
    Rogart RB; deBruyn Kops A; Dzau VJ
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7452-6. PubMed ID: 2429306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action of bepridil (CERM-1978) on calcium binding to cardiac sarcolemma of guinea pig.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1981 Aug; 30(16):2356-8. PubMed ID: 6975102
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H; Wallukat G; Vetter R; Will H
    Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of [3H]d-cis-diltiazem to cardiac sarcolemma and its inhibition by calcium.
    Balwierczak JL; Schwartz A
    Eur J Pharmacol; 1985 Oct; 116(1-2):193-4. PubMed ID: 2932342
    [No Abstract]   [Full Text] [Related]  

  • 13. Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes.
    Kanaya N; Matsumoto M; Kawana S; Tsuchida H; Kimura H; Miyamoto A; Ohshika H; Namiki A
    Can J Anaesth; 1998 Jun; 45(6):584-91. PubMed ID: 9669017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Propranolol beta-blocker decrease in the concentration of high-affinity binding sites for calcium ions by sarcolemma membranes of the rat heart].
    Seleznev IuM; Martynov AV; Smirnov VN
    Biull Eksp Biol Med; 1982 May; 93(5):72-4. PubMed ID: 7093513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halothane decreases calcium channel antagonist binding to cardiac membranes.
    Blanck TJ; Runge S; Stevenson RL
    Anesth Analg; 1988 Nov; 67(11):1032-5. PubMed ID: 2847594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a halothane-induced reduction in maximal calcium-activated force in mammalian myocardium.
    Berman MR; Casella ES; Blanck TJ
    Adv Exp Med Biol; 1991; 301():191-7. PubMed ID: 1763695
    [No Abstract]   [Full Text] [Related]  

  • 17. Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies.
    Williams JS; Grupp IL; Grupp G; Vaghy PL; Dumont L; Schwartz A; Yatani A; Hamilton S; Brown AM
    Biochem Biophys Res Commun; 1985 Aug; 131(1):13-21. PubMed ID: 2412552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
    Schilling WP; Zaher MC; Rampe D
    Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
    Balwierczak JL; Grupp IL; Grupp G; Schwartz A
    J Pharmacol Exp Ther; 1986 Apr; 237(1):40-8. PubMed ID: 2937911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.